Skip to content

Trevo Aspiration Proximal Flow Control Registry

TRevo Aspiration Proximal Flow Control for Endovascular Stroke Intervention Data Registry

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03199404
Acronym
TRAP
Enrollment
38
Registered
2017-06-26
Start date
2017-06-06
Completion date
2019-10-03
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Ischemic

Brief summary

This purpose of this retrospective, single-arm, non-randomized, multi-center study is to collect real-world data on the effectiveness of using the TRAP technique in acute ischemic stroke patients undergoing mechanical thrombectomy.

Detailed description

The TRAP Registry is designed to collect real-world data on the use of the TRAP technique for mechanical thrombectomy in stroke patients. Recanalization success (as assessed using a TICI Score), along with the time to recanalization and number of passes needed for success will be assessed at the conclusion of the procedure. In addition, neurologic recovery (as evaluated using the Modified Rankin Scale and National Institutes of Health Score) will be assessed at 24 hours, discharge, and 90 days after the thrombectomy procedure.

Interventions

DEVICETRAP

Mechanical thrombectomy performed with the combination of a stent retriever that is partially re-sheathed and withdrawn under constant aspiration along with the use of a balloon guide catheter for distal flow control during thrombectomy.

Sponsors

Stryker Neurovascular
CollaboratorINDUSTRY
University of Massachusetts, Worcester
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Subject experiencing an acute ischemic stroke in which imaging demonstrates a vascular occlusion located in the distal internal carotid artery (ICA) through the distal middle cerebral artery (MCA) * Subjects in which the TRAP technique is used for at least the first two thrombectomy passes per occluded vessel * Subjects that range in age from 18-85 * Subjects with a prestroke modified Rankin scale of 0-1 and presenting with an NIHSS of 8-30 * Subjects that the operator feels may be treated with endovascular therapy * Subjects in which computed tomography (CT)/Magnetic Resonance Imaging (MRI) demonstrates an infarct size of less than 70cc on MRI or Alberta Stroke Program Early CT (ASPECTS) score overall of 6 or better * Subjects in which groin puncture can be obtained within 6 hours of symptom onset (with or without Total Plasminogen Activator administration) * Subjects who have consented in accordance with local Institutional Review Board requirements

Exclusion criteria

* Absence of large vessel occlusion on neuroimaging * Evidence of tandem occlusion on neuroimaging * Platelet count \< 100 x 10³ cells/mm³ or known platelet dysfunction * Contraindication to CT and/or MRI (i.e., due to contrast allergy or prior implant that precludes MRI imaging) * Previously documented contrast allergy that is not amenable to medical treatment * Women who are pregnant or breastfeeding at time of intervention * Evidence of brain hemorrhage on CT and/or MRI at presenting hospital

Design outcomes

Primary

MeasureTime frameDescription
Distal EmboliDay 0: Conclusion of Thrombectomy ProcedureIncidence of distal emboli (both to affected vessel and new vessel) will be assessed
Recanalization after Endovascular InterventionDay 0: Conclusion of Thrombectomy ProcedureRevascularization as assessed via Thrombolysis in Cerebral Infarction (TICI) score (TICI 2b/3) in affected vessels
Time to RecanalizationDay 0: Conclusion of Thrombectomy ProcedureThe time required to attain recanalization (TICI 2b/3) in affected vessels
Number of Passes for RecanalizationDay 0: Conclusion of Thrombectomy ProcedureThe total number of passes with the stent retriever need to attain recanalization will be captured.

Secondary

MeasureTime frameDescription
Neurologic Outcomes90 days after treatmentNeurologic recovery as assessed by the National Institutes of Health Stroke Scale
Functional Outcomes90 days after treatmentNeurologic recovery as assessed by the Modified Rankin Scale
Adverse EventsDay 1, Day 5-7 and Day 90Incidence of serious procedure-related adverse events will be captured
TRAP TechniqueDay 0: Conclusion of thrombectomy procedureSuccess of using all components of the TRAP technique will be assessed by questionnaire for the interventionalist

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026